Inspection — Stellis Vaccines (VAX-014)
View validation registry →21 CFR Part 11 — ALCOA+
Anthropic token spend — last 7 days
0 tokens · 0 invocations · cap 2/day
Last invocation: never
Live activity
Auto-refreshes every 30sRBQM Analytics
every 15 minutesLast: 7d ago0 runs/24hAudit Trail
hourlyLast: never0 runs/24hEvaluation
daily 06:00 UTCLast: never0 runs/24hAnthropic budget today: 0 / 1 invocations (0%)green
Last model call: never
Cron counts and budget are platform-wide; study filter does not apply.
Page auto-refreshes every 30 seconds.
Agent Leaderboard
Agent leaderboard
Last 24h · Last 7d| Rank | Agent | Runs 24h · 7d | Signed 7d | Model % |
|---|---|---|---|---|
| 1. | 01-protocol-intake Protocol Intake | 0 · 0 | 0A2 | — |
| 2. | 02-site-qualification Site Qualification & Feasibility Scoring | 0 · 0 | 0A2 | — |
| 3. | 03-budget-cta Budget & CTA | 0 · 0 | 0A2 | — |
| 4. | 04-essential-documents Essential Documents | 0 · 0 | 0A3 | — |
| 5. | 05-feasibility-scoring Feasibility Scoring | 0 · 0 | 0A2 | — |
| 6. | 06-cohort-discovery Cohort Discovery | 0 · 0 | 0A2 | — |
| 7. | 07-site-monitoring Site Monitoring & Visit Planning | 0 · 0 | 0A2 | — |
| 8. | 08-program-orchestration Program Orchestration | 0 · 0 | 0A2 | — |
| 9. | 09-status-communications Status & Communications | 0 · 0 | 0A1 | — |
| 10. | 10-rbqm-risk RBQM Risk Assessment | 0 · 0 | 0A2 | — |
Showing top 10 of 34 agentsView full roster →
Agent Roster
Agent Roster (34)
A0 deterministic · A1 assistive · A2 supervised · A3 human-on-the-loop · A4 prohibitedCompare agents →Start-Up & Regulatory (3)
| ID | Name | Autonomy | Phase | Human gate |
|---|---|---|---|---|
| #01-protocol-intake | Protocol Intake Ingests protocol PDFs; produces structured analysis (population, endpoints, schedule of assessments). | A2 | Phase 3 | Operations + Medical review |
| #03-budget-cta | Budget & CTA Itemised study budgets, Medicare Coverage Analysis tagging, CTA redlines against negotiation playbook. | A2 | Phase 2 | Finance Lead + Legal Reviewer |
| #04-essential-documents | Essential Documents Continuous classification, naming, filing, and completeness checking of regulatory / eTMF documents. | A3 | Phase 1 | QA / Regulatory (A2 for completeness sign-off) |
Feasibility & Patient/Site ID (3)
| ID | Name | Autonomy | Phase | Human gate |
|---|---|---|---|---|
| #02-site-qualification | Site Qualification & Feasibility Scoring Scores candidate sites against feasibility criteria and prior performance. | A2 | Phase 3 | Medical / CRA review |
| #05-feasibility-scoring | Feasibility Scoring Scores site and population fit using RWD, EHR-derived counts, and prior enrollment performance. | A2 | Phase 2 | Feasibility Lead |
| #06-cohort-discovery | Cohort Discovery Queries EHR / claims to estimate eligible population with per-criterion attrition funnel. | A2 | Phase 2 | Medical review (eligibility logic) |
Clinical Monitoring (RBQM) (4)
| ID | Name | Autonomy | Phase | Human gate |
|---|---|---|---|---|
| #07-site-monitoring | Site Monitoring & Visit Planning Analyses CTMS/EDC site performance metrics; produces a deterministic VisitPlan with for-cause overrides. | A2 | Phase 3 | CRA Manager |
| #10-rbqm-risk | RBQM Risk Assessment Fully deterministic study risk profiling by domain; produces StudyRiskProfile with escalation items. | A2 | Phase 3 | RBQM Lead |
| #11-rbqm-signal | RBQM Signal Detection & Escalation Deterministic z-score statistics + LLM-generated narrative for signal explainability. | A2 | Phase 3 | Clinical Operations Lead |
| #12-rbqm-analytics | RBQM Analytics / CSM Dashboard Deterministic site rankings and global quality index; model only for narrative summaries. | A2 | Phase 3 | CSM Lead |
Project & Program Management (2)
| ID | Name | Autonomy | Phase | Human gate |
|---|---|---|---|---|
| #08-program-orchestration | Program Orchestration Maintains master timeline; models critical path; forecasts milestone slippage. | A2 | Phase 2 | Project Lead (A2 for sponsor-facing forecasts) |
| #09-status-communications | Status & Communications Drafts pre-reads, minutes, action trackers (A1); routine internal status (A3); sponsor-facing forces A2 + sign-off. | A1 | Phase 2 | Project Lead reviews outbound sponsor communications |
Data Management (4)
| ID | Name | Autonomy | Phase | Human gate |
|---|---|---|---|---|
| #13-data-validation | Data Validation Runs and generates edit checks; detects discrepancies and deviations in incoming data. | A3 | Phase 2 | Data Manager (A2 for the validation plan itself) |
| #14-query-resolution | Query Resolution Drafts, routes, tracks, and closes data queries — staged for CRA/DM review before site delivery. | A3 | Phase 2 | Data Manager (A2 for query content) |
| #15-coding | Medical Coding (MedDRA / WHODrug) Codes adverse events and medications to MedDRA/WHODrug with confidence scoring; low confidence escalates. | A2 | Phase 2 | Medical / data review |
| #16-cdisc-mapping | CDISC Mapping (SDTM / ADaM) Maps raw study data to SDTM and derives ADaM datasets; double-mapping QC pattern for pivotal studies. | A2 | Phase 2 | Data Manager / Statistical Programmer |
Biostatistics (3)
| ID | Name | Autonomy | Phase | Human gate |
|---|---|---|---|---|
| #17-sap-drafting | SAP Drafting Drafts the statistical analysis plan from the protocol and endpoint definitions; assistive only. | A1 | Phase 4 | Qualified statistician — SAP sign-off is non-delegable |
| #18-tlf-generation | TLF Generation (+ Double Programming) Generates TLF code and outputs under double-programming verification; verificationPassed clamped to zero diffs. | A2 | Phase 4 | Statistician — with mandatory independent verification |
| #19-trial-simulation | Trial Simulation Sample-size estimation, adaptive-design simulation, scenario modeling — assistive only. | A1 | Phase 2 | Statistician |
Medical Writing (4)
| ID | Name | Autonomy | Phase | Human gate |
|---|---|---|---|---|
| #20-protocol-authoring | Protocol Authoring Drafts protocols and amendments section-by-section per ICH M11 / E6(R3) / E8(R1). | A2 | Phase 4 | Medical Writer + Medical Officer (dual sign-off) |
| #21-csr-authoring | CSR Authoring Drafts ICH E3 CSR sections; every number traceable to a signed TLF; every claim cited. | A2 | Phase 4 | Medical Writer + Medical Officer + Statistician (triple sign-off) |
| #22-medical-writing | Clinical Writing Assistant Citation-grounded authoring support for clinical narratives; empty citedSources rejects output. | A1 | Phase 3 | Medical Writer |
| #23-plain-language-summary | Plain-Language Summary Generates EU CTR Annex V lay summaries; deterministic Flesch-Kincaid / Flesch Reading Ease gating. | A2 | Phase 4 | Medical review |
Pharmacovigilance & Safety (3)
| ID | Name | Autonomy | Phase | Human gate |
|---|---|---|---|---|
| #24-ae-detection | Adverse Event Detection & Extraction Identifies and structures AE records from narrative source documents. NO causality field — architecturally enforced. | A2 | Phase 3 | PV Lead |
| #25-pv-signal | PV Signal Detection Deterministic ROR / PRR disproportionality analysis; LLM only for narrative context. | A2 | Phase 3 | Safety Physician — causality determination non-delegable |
| #26-susar-drafting | SUSAR Report Drafting Drafts SUSAR narratives per ICH E2A; NO causality field; dual sign-off enforced before promotion. | A2 | Phase 3 | Safety Physician + Regulatory Affairs (dual sign-off) |
Quality Assurance & Compliance (3)
| ID | Name | Autonomy | Phase | Human gate |
|---|---|---|---|---|
| #27-audit-trail | Continuous Audit-Trail Monitors audit trails across every system for anomalies, access violations, integrity issues. | A2 | Phase 1 | QA Lead (A2 for findings) |
| #28-inspection-readiness | Inspection Readiness Scores eTMF, deviation log, training records, and 5 other inspection domains; tracks CAPAs. | A2 | Phase 2 | QA Lead |
| #29-deviation-detection | Deviation Detection Detects protocol and GCP deviations from operational events; stages pending-classification for QA sign-off. | A2 | Phase 2 | Classification (minor/major/critical) is human-signed |
Cross-Cutting Platform (2)
| ID | Name | Autonomy | Phase | Human gate |
|---|---|---|---|---|
| #30-knowledge-rag | Knowledge / Regulatory RAG Answers any agent or human question against the corpus with cited sources; citation enforcement non-negotiable. | A1 | Phase 1 | Human asks — human decides |
| #31-evaluation | Evaluation Continuously tests other agents against golden datasets; detects performance drift; triggers revalidation. | A0 | Phase 1 | Part of the validation system — never a study deliverable |
Commercial & Growth (3)
| ID | Name | Autonomy | Phase | Human gate |
|---|---|---|---|---|
| #32-opportunity-sourcing | BD Opportunity Sourcing Surfaces and ranks new research opportunities (sponsors, indications, RFPs) from permissible sources; never contacts a sponsor or uses confidential intel. | A2 | Phase 4 | BD / Capture Lead |
| #33-capture-funnel | Capture & Bid Funnel Moves opportunities through sourced→qualified→bid→proposal→bid-defense→award with win-likelihood; pricing and award are always human acts. | A2 | Phase 4 | BD Lead + Proposals |
| #34-patient-recruitment | Patient Identification & Recruitment Identifies likely-eligible candidates from de-identified/tokenized registries and runs a consent funnel; no PHI in staging, IRB-approved outreach only, clinician-confirmed eligibility. | A2 | Phase 4 | Recruitment Lead + Clinician (eligibility); IRB for outreach |
Validation Scorecards
validation-evidence
Agent 27-audit-trail · 6/4/2026, 5:12:49 PM
0% pass
1/0 cases
validation-evidence
Agent 27-audit-trail · 6/4/2026, 5:12:49 PM
0% pass
1/0 cases
validation-evidence
Agent 27-audit-trail · 6/4/2026, 5:12:49 PM
0% pass
1/0 cases
Audit-trail integrity
Hash-chained, append-only provenance and signature tables (ADR 0012). Any deletion, reordering, or edit breaks the chain and is detected here.
Verifying chain…
Provenance Events for VAX-014 (0 of 0 last 7 days)
No provenance events recorded yet for VAX-014.